Amarin’s AMR101 for Huntington’s disease Marketing Authorization Application accepted for review by EMEA
April 8, 2009
Read more ยป
Home
ProSeed Capital
About
Investor Extranet
News Releases
Our Committees
Partners
Portfolio
Team
Advisory Services
Biotech Services
About
Team
Search:
Your Privacy
|
Legal Notes
| info@proseedcapital.com
